Here's what Jim Cramer thinks about J&J stock after a pivotal talc case verdict

J&J was ordered to pay $18.8 million after jurors in California found in favor of a 24-year-old man who claimed the company's talc products caused his cancer.

Here's what Jim Cramer thinks about J&J stock after a pivotal talc case verdict

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. 

Justin Sullivan | Getty Images

A closely watched talc trial in California goes against Johnson & Johnson (JNJ), adding uncertainty around whether tens of thousands of other plaintiffs suing the company will sign on to J&J's proposed $8.9 billion settlement offer or seek to get their own days in court.